Publications of Udo Reichl

Reichl, U. & Gilles, E. D. (1990)Investigations of pellet forming microorganisms by means of an image processing systemIn: 5th European Congress on Biotechnology: Vol. 2, 1166–1170.

Reichl, U. & Gilles, E. D. (1990)Early growth of Streptomyces in submerged cultureIn: 8th DECHEMA annual meeting of biotechnologists, 825–828.

Reichl, U. (1989)Use of an image processing system for investigation of the morphology of filamentously growing microorganismsIn: 7th DECHEMA annual meeting of biotechnologists.

Rudert, J., Bälkner, M., Juárez-Osorio, M., Rexer, T., Reichl, U., Jacobsen, H., Metzdorf, K., Bruder, D., & Volckmar, J. (2023)Adjuvanted SARS-CoV-2 spike protein vaccination with altered glycosylation elicits improved TH1 humoral and cellular immunity in miceIn: European Journal of Immunology, P376doi: 10.1002/eji.202370300.

Bürgin, T., Coronel, J., Fiddeke, K., Karlas, A., Sandig, V., Genzel, Y., Reichl, U., & Anderlei, T. (2022)Producing viruses in orbit: Current developments for orbital shaken viral vaccine manufacturingIn: Proceedings Vaccine Technology VIII, 54.

Göbel, S., Dorn, M., Jaén Chavez, K., Jordan, I., Sandig, V., Altomonte, J., Genzel, Y., & Reichl, U. (2022)Production of a fusogenic oncolytic rVSV-NDV virus in perfusion processesIn: Proceedings Vaccine Technology VIII, 60.

Göbel, S., Pelz, L., Behrendt, I., Prömmel, M., Altomonte, J., Anderlei, T., Bürgin, T., Genzel, Y., & Reichl, U. (2022)Scale-Down of an Ortbital Shaken Bioreactor: High Cell Density Cultivation in Perfusion Mode and Virus productionIn: Proceedings Single-Use Technologies V: Building the Future, 40.

Offersgaard, A., Duarte Hernandez, C. R., Pihl, A. F., Costa, R., Prabhakar Venkatesan, N., Lin, X., Van Pham, L., Feng, S., Fahnøe, U., Høyer Scheel, T. K., Ramirez, S., Reichl, U., Bukh, J., Genzel, Y., & Gottwein, J. M. (2022)SARS-COV-2 production in a single-use scalable high cell density bioreactorIn: Proceedings Single-Use Technologies V: Building the Future, 29.

Zinnecker, T. M., Behrendt, I., Lau, M., Hinkelmann, A., Thiele, K., Badri, N., Araujo, D., Genzel, Y., & Reichl, U. (2022)Automated single-cell cloning in chemically defined medium for new suspension MDCK cell lines and scale-down of influenza A virus production into ambr^®15 microbioreactorsIn: Proceedings Vaccine Technology VIII, 55.

Hein, M., Tapia, F., Genzel, Y., Kupke, S. Y., & Reichl, U. (2019)Continuous mode of production for two classes of defective interfering influenza A virus particles as antiviral candidatesIn: Integrated Continuous Biomanufacturing IV, 76.

Marichal-Gallardo, P., Genzel, Y., Börner, K., Grimm, D., Wolff, M. W., & Reichl, U. (2019)A single-use chromatographic purification platform for viral gene transfer vectors & viral vaccinesIn: Proceedings Advancing Manufacture of Cell and Gene Therapies VI, 92.

Bissinger, T., Reichl, U., Genzel, Y., Wu, Y., Liu, X., & Tan, W.-S. (2018)Highly efficient influenza virus production: A MDCK-based high-cell-density processIn: Vaccine Technology VII, 13.

Coronel, J., Genzel, Y., Reichl, U., Behrendt, I., Buergin, T., Andereli, T., & Sandig, V. (2018)Orbital shaken bioreactor for influenza A virus production in high cell density cultivationsIn: Vaccine Technology VII, 40.

Fortuna, A. R., Taft, F., Villain, L., Wolff, M. W., & Reichl, U. (2018)Continuous purification of cell culture-derived influenza A virus particles through pseudo- affinity membrane chromatographyIn: Vaccine Technology VII, 124.

Gränicher, G., Genzel, Y., Reichl, U., John, K., Sandig, V., & Karlas, A. (2018)A new porcine suspension cell line (PBG.PK-21) provides efficient production for influenza and yellow fever vaccine virusesIn: Vaccine Technology VII, 48.

Kupke, S. Y., Riedel, D., Frensing, T., Zmora, P., & Reichl, U. (2018)Single-cell analysis uncovers a novel influenza A virus-derived defective interfering particle for antiviral therapyIn: Vaccine Technology VII, 133.

Marichal-Gallardo, P., Fortuna, A. R., Genzel, Y., Wolff, M. W., & Reichl, U. (2018)Purifying viruses with a sheet of paper: Single-use steric exclusion chromatography as a capture platform for vaccine candidatesIn: Vaccine Technology VII, 128.

Nikolay, A., Genzel, Y., Schwamborn, K., Leon, A., & Reichl, U. (2018)Flavivirus production in perfusion processes using the EB66® cell lineIn: Vaccine Technology VII, 80.

Peixoto, C., Carvalho, S. B., Carrondo, M. J. T., Alves , P. M., Fortuna, A. R., Reichl, U., & Wolff, M. W. (2018)Addressing the challenges of influenza virus-like particles purificationIn: Vaccine Technology VII, 57.

Taft, F., Köhler, R., Van Teeffelen, S., Fortuna, A. R., Wolff, M. W., Reichl, U., Villain, L., & Boulais, A. (2018)Influenza virus capture using membrane chromatography: Improving selectivity by matrix design and pseudo-affinity ligand interactionsIn: Vaccine Technology VII, 75.